Literature DB >> 25191509

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression.

Yi-Cheng Hou1, Chien-Han Lai2.   

Abstract

The atypical antipsychotics were believed to induce less extrapyramidal syndrome, including tardive dyskinesia (TD). Since the introduction of the quetiapine, it is also reported with less TD side effects. It even can relieve the symptoms of severe TD and reduce the risk of TD. The quetiapine's low affinity and fast dissociation from postsynaptic dopamine D2 receptors should give the least risk of producing the symptoms of TD. The quetiapine even can reduce the TD side effects related to clozapine, which has the lowest risk for TD. However, since the first case report of TD side effects related to quetiapine published on 1999, the safety of quetiapine in TD aspect has been questioned. Therefore, we want to share this case report, which was written to describe the severe late-onset TD side effects after long-term use of quetiapine in a patient with psychotic depression. The patient had no significant findings after concurrent comprehensive neurological examinations, magnetic resonance imaging of brain and electroencephalogram since the onset of TD.

Entities:  

Keywords:  Psychotic depression; Quetiapine; Tardive dyskinesia

Year:  2014        PMID: 25191509      PMCID: PMC4153865          DOI: 10.9758/cpn.2014.12.2.163

Source DB:  PubMed          Journal:  Clin Psychopharmacol Neurosci        ISSN: 1738-1088            Impact factor:   2.582


  19 in total

1.  Reduction of tardive dyskinesia with quetiapine.

Authors:  A Farah
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.

Authors:  C Vesely; B Küfferle; T Brücke; S Kasper
Journal:  Int Clin Psychopharmacol       Date:  2000-01       Impact factor: 1.659

3.  Tardive dyskinesia with quetiapine.

Authors:  D Ghelber; R H Belmaker
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

4.  Tardive dyskinesia related to quetiapine and confirmed by a DAT scan.

Authors:  Sofia N Chatziioannou; Emmanouil N Rizos; Maria Kallergi; Athannasios Douzenis; Athannasios Apostolopoulos; Sotiris Bacalis; Lefteris Lykouras
Journal:  J Clin Psychopharmacol       Date:  2011-08       Impact factor: 3.153

Review 5.  Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.

Authors:  S Ono; Y Suzuki; M Shindo; T Endo; N Fukui; T Sugai; T Someya
Journal:  J Clin Pharm Ther       Date:  2011-10-24       Impact factor: 2.512

6.  Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.

Authors:  Philippos Gourzis; Panagiotis Polychronopoulos; Spiridon Papapetropoulos; Konstantinos Assimakopoulos; Andreas A Argyriou; Stavroula Beratis
Journal:  Clin Neuropharmacol       Date:  2005 Jul-Aug       Impact factor: 1.592

7.  Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.

Authors:  K Alptekin; B B Kivircik
Journal:  Int Clin Psychopharmacol       Date:  2002-09       Impact factor: 1.659

8.  Tardive dyskinesia in a patient treated with quetiapine.

Authors:  Emmanouil Rizos; Athanassios Douzenis; Rossetos Gournellis; Christos Christodoulou; Lefteris P Lykouras
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

Review 9.  Clinical use of quetiapine in disease states other than schizophrenia.

Authors:  S Charles Schulz
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

10.  A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Authors:  Robin Emsley; H Jadri Turner; Juan Schronen; Karien Botha; Retha Smit; Piet P Oosthuizen
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.